Nurse Practitioner, Adult Health · New York, NY
NPI
1437311073
Since 2008
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1275 York Ave
New York, NY, 10065
Phone (212) 639-6711
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
189 services
Medicare patients, 2024
113
Average age 74
Drug cost, 2024
$3.5M
772 prescriptions
Company payments, 2025
$15.51
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bernadette Cuello was code 99213 (office e&m - established), 99 times for 63 patients. In total Bernadette Cuello billed 189 services in 4 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-06-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 99 | 63 | $45.93 | $4,547 |
| 99214 Office E&M - Established | Office | 63 | 38 | $69.92 | $4,405 |
| 38222 Other Organ Systems | Office | 26 | 24 | $51.49 | $1,339 |
By year: 2022 $13K for 232 services; 2023 $17K for 289 services; 2024 $10K for 189 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bernadette Cuello prescribed most often to Medicare patients was Acyclovir, with 114 prescriptions and refills. In total Bernadette Cuello wrote 772 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 114 | 187 | 38 | $1,633 |
| Hydroxyurea Generic | 61 | 95 | 22 | $1,146 |
| Levofloxacin Generic | 60 | 70 | 27 | $495 |
| Jakafi Ruxolitinib Phosphate | 41 | 47 | Under 11 | $881K |
| Venclexta Venetoclax | 35 | 36 | 20 | $246K |
| Imatinib Mesylate Generic | 33 | 41 | Under 11 | $13K |
| Allopurinol Generic | 30 | 42 | 13 | $201 |
| Posaconazole Generic | 27 | 31 | 12 | $28K |
| Prednisone Generic | 20 | 22 | Under 11 | $83.3 |
| Cefixime Generic | 17 | 17 | Under 11 | $4,236 |
| Sprycel Dasatinib | 17 | 17 | Under 11 | $191K |
| Gleevec Imatinib Mesylate | 17 | 31 | Under 11 | $216K |
| Ojjaara Momelotinib Dihydrochloride | 15 | 15 | Under 11 | $408K |
| Pantoprazole Sodium Generic | 15 | 19 | Under 11 | $146 |
| Voriconazole Generic | 14 | 15 | Under 11 | $6,199 |
Brand drugs: - claims; generic drugs: 527 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bernadette Cuello $15.51 ($15.51 in general payments such as food, travel and fees) from 1 company. The largest payer was Shorla Oncology Inc. with $15.51.
| Company | Payments | Amount |
|---|---|---|
| Shorla Oncology Inc. | 1 | $15.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.